Effect of the definition of type II diabetes remission in the evaluation of bariatric surgery for metabolic disorders
British journal of surgery2011Vol. 99(1), pp. 100–103
Citations Over TimeTop 1% of 2011 papers
Dimitri J. Pournaras, Erlend T. Aasheim, Torgeir T. Søvik, Robert Andrews, David Mahon, Richard Welbourn, Torsten Olbers, Carel W. le Roux
Abstract
Expectations of patients and clinicians may have to be adjusted as regards remission of type II diabetes after bariatric surgery. Focusing on improved glycaemic control rather than remission may better reflect the benefit of this type of surgery and facilitate improved glycaemic control after surgery.
Related Papers
- → Patients’ reasons for and against undergoing Roux-en-Y gastric bypass, adjustable gastric banding, and vertical sleeve gastrectomy(2017)25 cited
- → 30-Day outcomes of Sleeve Gastrectomy (SG) vs Roux en Y Gastric Bypass (RYGB): First Look at MBSAQIP data(2017)
- → MBSAQIP National Registry Study of Robotic-assisted Outcomes in Patients Undergoing Sleeve Gastrectomy or Roux-en-Y Gastric Bypass(2018)
- → Remission of comorbidities, weight loss, and adverse events after Sleeve Gastrectomy and Roux-en-Y gastric bypass in patients with obesity(2021)
- → A164 Long term weight loss outcomes and major adverse cardiovascular events after Roux-en-Y gastric bypass and sleeve gastrectomy: experience from two MBSAQIP centers(2024)